the board of directors of the company inter-alia : 1. Approved the audited finacial results for the quater/year ended 31st March, 2026, 2. Reccomended a dividend @ 40% i.e., Rs 4 per ....
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indraprastha Medical Corporation Limited (Apollo Hospitals, Delhi) reported audited financial results for FY 2025-26. Total income grew 9.6% to Rs. 1,511.26 crore from Rs. 1,379.01 crore in the prior year, driven by revenue from operations of Rs. 1,482.51 crore (up 9.3% YoY). Profit After Tax (PAT) rose 14% to Rs. 183.62 crore vs Rs. 160.99 crore, while EPS improved from Rs. 17.56 to Rs. 20.03 per share. The Board recommended a dividend of Rs. 4 per share (40%), down from Rs. 4.50 per share (45%) in the previous year, subject to shareholder approval at the AGM. Auditors issued an unmodified (clean) opinion, and the company is not classified as a 'Large Corporate' under SEBI norms. Cash generated from operations was Rs. 167.44 crore.
Revenue and profit growth indicate healthy operational performance. The dividend cut from Rs. 4.50 to Rs. 4 may be viewed cautiously by income-focused investors, though the improving EPS and cash generation support the company's financial stability.